We are creating some awesome events for you. Kindly bear with us.

Saliva Testing Tech Rolled Out to Combat Covid-19 in Indonesia

Pharmaceutical and biotechnology companies all over the world are responding to the COVID-19 pandemic’s challenges. The biotech industry was instrumental in developing and shipping COVID-19 vaccines in record time. Biotechnology Innovation Organization (BIO) leaders have stated that biotech is playing a role in the pandemic.

Many biotechnology companies shifted their focus to infectious disease research during the COVID-19 pandemic. There were 191 COVID-19 vaccine candidates in development as of January 5, 2021, and over 800 clinical trials for various drugs and vaccines, many of which are being developed by companies with no prior experience in the infectious disease sector.

As biotech companies from other countries try their hardest to develop a ‘game changing’ vaccine, two biotech start-up companies from Indonesia have recently developed saliva-based COVID-19 (PCR test kits) that can detect COVID-19 from saliva samples. These kits will function as alternatives to nasal and throat swab tests.

As per a press release distributed by the company, the test kit invention from one of the biotech companies has an accuracy of ‘up to 97%’. Multiple labs and hospital partners have validated the kit’s performance, and the results have been published in a peer-reviewed journal. Since receiving a swab test can be uncomfortable and even painful for some people, the saliva-based test kit provides a convenient option that is suitable for both children and seniors. The test kit also does not require extraction, is inexpensive, and can be self-administered.

Meanwhile, the second biotech firm collaborated with a state-owned pharmaceutical company to launch its own saliva product, a test in which subjects gargle a test solution. The company’s previous product, a nasal swab test, is now complemented by the latest invention. Consequently, this saliva test invention can detect ten COVID-19 mutation variants, including the kappa and delta variants, which are said to be more infectious than others. According to a press release from the start-up, the new test kit has an accuracy of ‘up to 95%’. Its development process involved more than 400 samples from COVID-19 patients, including outpatients and inpatients, as well as validation research over the course of seven months.

Both biotech start-ups hope that the new test kits will strengthen Indonesia’s COVID-19 tracing capabilities. Subjects do not need to visit medical facilities to produce samples because the administration of both test devices does not require medical training, allowing them to avoid crowded areas and reduce the risk of viral transmission.

Indonesia is currently struggling with surging cases of COVID-19 infections. As of now, there have been 2.3 million confirmed cases, with 61,140 deaths reported. Medical facilities across Java are being overwhelmed by an influx of new patients, and people who do not have severe symptoms are being turned away from hospitals because they are all overcrowded. This has led to a shortage of medical supplies, especially oxygen cylinders.

Nevertheless, with the help of these systems, it could possibly ease the covid-19 treatment in Indonesia. Furthermore, Indonesia has also prepared backup medical facilities and plans to start importing oxygen tanks as the country battles a fresh wave of coronavirus infections that has overwhelmed its medical system.

Today, leaders around the world are looking to biotechnology and pharmaceutical companies for possible solutions to the COVID-19 pandemic, which include diagnostic assays and therapeutics, as well as prophylactic vaccines and advanced test kits.

While digital technologies provide tools to aid in pandemic response, they are not a panacea. The emerging consensus is that they play an important role in a comprehensive response to outbreaks and pandemics, supplementing traditional public-health measures and thus contributing to the reduction of COVID-19’s human and economic impact.


Qlik’s vision is a data-literate world, where everyone can use data and analytics to improve decision-making and solve their most challenging problems. A private company, Qlik offers real-time data integration and analytics solutions, powered by Qlik Cloud, to close the gaps between data, insights and action. By transforming data into Active Intelligence, businesses can drive better decisions, improve revenue and profitability, and optimize customer relationships. Qlik serves more than 38,000 active customers in over 100 countries.


CTC Global Singapore, a premier end-to-end IT solutions provider, is a fully owned subsidiary of ITOCHU Techno-Solutions Corporation (CTC) and ITOCHU Corporation.

Since 1972, CTC has established itself as one of the country’s top IT solutions providers. With 50 years of experience, headed by an experienced management team and staffed by over 200 qualified IT professionals, we support organizations with integrated IT solutions expertise in Autonomous IT, Cyber Security, Digital Transformation, Enterprise Cloud Infrastructure, Workplace Modernization and Professional Services.

Well-known for our strengths in system integration and consultation, CTC Global proves to be the preferred IT outsourcing destination for organizations all over Singapore today.


Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions creates an organizational focus on the strategic outcomes that matter and empowers teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enables customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas, with locations around the world, Planview has more than 1,300 employees supporting 4,500 customers and 2.6 million users worldwide. For more information, visit www.planview.com.


SIRIM is a premier industrial research and technology organisation in Malaysia, wholly-owned by the Minister​ of Finance Incorporated. With over forty years of experience and expertise, SIRIM is mandated as the machinery for research and technology development, and the national champion of quality. SIRIM has always played a major role in the development of the country’s private sector. By tapping into our expertise and knowledge base, we focus on developing new technologies and improvements in the manufacturing, technology and services sectors. We nurture Small Medium Enterprises (SME) growth with solutions for technology penetration and upgrading, making it an ideal technology partner for SMEs.


HashiCorp provides infrastructure automation software for multi-cloud environments, enabling enterprises to unlock a common cloud operating model to provision, secure, connect, and run any application on any infrastructure. HashiCorp tools allow organizations to deliver applications faster by helping enterprises transition from manual processes and ITIL practices to self-service automation and DevOps practices. 


IBM is a leading global hybrid cloud and AI, and business services provider. We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries. Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely. IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients. All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

Send this to a friend